Amyloidosis centre steps away from mainstream support
Lead nuclear medicine technologist David Hutt with AGB’s Phil Facey. The National Amyloidosis Centre at the Royal Free Hospital has become a new customer of Ashby Gorman Baker (AGB). The centre has provided a diagnostic, staging, monitoring and management advisory service for the national caseload of patients with amyloidosis since it was commissioned by the […]
Read More